
1. Bremer J. Carnitine—metabolism and functions. *Physiol Rev*. 1983;63(4):1420–1480. doi:10.1152/physrev.1983.63.4.1420
2. Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. *Annu Rev Nutr*. 1998;18:39–61. doi:10.1146/annurev.nutr.18.1.39
3. Brass EP. Supplemental carnitine and exercise. *Am J Clin Nutr*. 2000;72(2 Suppl):618S–623S. doi:10.1093/ajcn/72.2.618S
4. Wall BT, et al. L-Carnitine supplementation increases skeletal muscle carnitine content and alters muscle fuel metabolism in humans. *J Physiol*. 2011;589(Pt 4):963–973. doi:10.1113/jphysiol.2010.201343
5. Hiatt WR, et al. Carnitine and peripheral arterial disease: clinical trial evidence. *J Am Coll Cardiol*. 1995;26(5):1199–1204. doi:10.1016/0735-1097(95)00306-6
6. Malaguarnera M, et al. L-Carnitine supplementation reduces oxidative stress in type 2 diabetes patients. *Diabetes Metab*. 2009;35(6):447–454. doi:10.1016/j.diabet.2009.05.001
7. Montgomery SA, et al. Acetyl-L-carnitine in the treatment of depression. *Int Clin Psychopharmacol*. 2003;18(1):45–49. doi:10.1097/00004850-200301000-00007
8. Pettegrew JW, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease. *Neurobiol Aging*. 1995;16(1):1–4. doi:10.1016/0197-4580(95)80001-8
9. Galloway SDR, et al. Effects of carnitine supplementation on exercise performance and recovery. *J Sports Sci*. 2004;22(9):855–866. doi:10.1080/02640410410001716739
10. Flanagan JL, et al. L-Carnitine and acetyl-L-carnitine in the treatment of metabolic disease and aging. *Ann N Y Acad Sci*. 2010;1205:87–95. doi:10.1111/j.1749-6632.2010.05656.x
2. Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. *Annu Rev Nutr*. 1998;18:39–61. doi:10.1146/annurev.nutr.18.1.39
3. Brass EP. Supplemental carnitine and exercise. *Am J Clin Nutr*. 2000;72(2 Suppl):618S–623S. doi:10.1093/ajcn/72.2.618S
4. Wall BT, et al. L-Carnitine supplementation increases skeletal muscle carnitine content and alters muscle fuel metabolism in humans. *J Physiol*. 2011;589(Pt 4):963–973. doi:10.1113/jphysiol.2010.201343
5. Hiatt WR, et al. Carnitine and peripheral arterial disease: clinical trial evidence. *J Am Coll Cardiol*. 1995;26(5):1199–1204. doi:10.1016/0735-1097(95)00306-6
6. Malaguarnera M, et al. L-Carnitine supplementation reduces oxidative stress in type 2 diabetes patients. *Diabetes Metab*. 2009;35(6):447–454. doi:10.1016/j.diabet.2009.05.001
7. Montgomery SA, et al. Acetyl-L-carnitine in the treatment of depression. *Int Clin Psychopharmacol*. 2003;18(1):45–49. doi:10.1097/00004850-200301000-00007
8. Pettegrew JW, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease. *Neurobiol Aging*. 1995;16(1):1–4. doi:10.1016/0197-4580(95)80001-8
9. Galloway SDR, et al. Effects of carnitine supplementation on exercise performance and recovery. *J Sports Sci*. 2004;22(9):855–866. doi:10.1080/02640410410001716739
10. Flanagan JL, et al. L-Carnitine and acetyl-L-carnitine in the treatment of metabolic disease and aging. *Ann N Y Acad Sci*. 2010;1205:87–95. doi:10.1111/j.1749-6632.2010.05656.x